BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16575920)

  • 1. Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray.
    Gosalia DN; Denney WS; Salisbury CM; Ellman JA; Diamond SL
    Biotechnol Bioeng; 2006 Aug; 94(6):1099-110. PubMed ID: 16575920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of a SAW-biosensor with MALDI mass spectrometric analysis.
    Treitz G; Gronewold TM; Quandt E; Zabe-Kühn M
    Biosens Bioelectron; 2008 May; 23(10):1496-502. PubMed ID: 18316185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nature of the proteinase activated by the contact factor in human blood plasma].
    Veremeenko KN; Kizim AI; Lositskaia VM
    Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance-enabled mass spectrometry arrays.
    Nedelkov D; Tubbs KA; Nelson RW
    Electrophoresis; 2006 Sep; 27(18):3671-5. PubMed ID: 16915566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Maly DJ; Ellman JA; Diamond SL
    Proteomics; 2005 Apr; 5(5):1292-8. PubMed ID: 15742319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Ellman JA; Diamond SL
    Mol Cell Proteomics; 2005 May; 4(5):626-36. PubMed ID: 15705970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide microarrays for serum antibody diagnostics.
    Andresen H; Bier FF
    Methods Mol Biol; 2009; 509():123-34. PubMed ID: 19212718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-assisted protease substrate screening.
    Schlüter H; Rykl J; Thiemann J; Kurzawski S; Gobom J; Tepel M; Zidek W; Linscheid M
    Anal Chem; 2007 Feb; 79(3):1251-5. PubMed ID: 17263361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of active coagulation factors in Autoplex-T with colorimetric active site-specific assay technology.
    Lundblad RL; Bergstrom J; De Vreker R; Bray G; Gomperts E; Baker D; Kingdon HS; Mann KG; Hartshorn J; Jenny RJ
    Thromb Haemost; 1998 Nov; 80(5):811-5. PubMed ID: 9843176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon resonance and surface plasmon field-enhanced fluorescence spectroscopy for sensitive detection of tumor markers.
    Arima Y; Teramura Y; Takiguchi H; Kawano K; Kotera H; Iwata H
    Methods Mol Biol; 2009; 503():3-20. PubMed ID: 19151933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A possible approach to the analysis of protease mixtures].
    Nedospasov AA; Nezavibat'ko VN; Potaman VN; Rodina EV
    Izv Akad Nauk SSSR Biol; 1989; (1):128-32. PubMed ID: 2654236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of various fluorogenic substrates for determining peptide hydrolase activity of the blood serum].
    Dilakian EA; Lokshina LA; Molodyk AA; Orekhovich VN; Pozdnev VF
    Vopr Med Khim; 1989; 35(1):131-6. PubMed ID: 2662594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future aspects of bioprocess monitoring.
    Becker T; Hitzmann B; Muffler K; Pörtner R; Reardon KF; Stahl F; Ulber R
    Adv Biochem Eng Biotechnol; 2007; 105():249-93. PubMed ID: 17408086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of microarray slides as substrates for the development of protease assay biosensors.
    Darr CM; Castorena J; Korampally V; Gangopadhyay S; Polo-Parada L
    Exp Mol Pathol; 2011 Dec; 91(3):714-7. PubMed ID: 21945735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroimmunoassays using the NRL array biosensor.
    Golden JP; Sapsford KE
    Methods Mol Biol; 2009; 503():273-92. PubMed ID: 19151947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNA-encoded protease substrate microarrays.
    Winssinger N; Damoiseaux R; Tully DC; Geierstanger BH; Burdick K; Harris JL
    Chem Biol; 2004 Oct; 11(10):1351-60. PubMed ID: 15489162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for mapping protease specificity.
    Diamond SL
    Curr Opin Chem Biol; 2007 Feb; 11(1):46-51. PubMed ID: 17157549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.